Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.

por Englefield, P., Foulkes, W. D., Campbell, I. G.
Publicado 1994

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

por Mavridou, D., Gornall, R., Campbell, I. G., Eccles, D. M.
Publicado 1998

BRCA1 polymorphisms.

por Campbell, I. G., Schroff, R., Englefield, P., Eccles, D. M.
Publicado 1997

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.

por Manolitsas, T. P., Englefield, P., Eccles, D. M., Campbell, I. G.
Publicado 1997

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

por Foulkes, W. D., Campbell, I. G., Stamp, G. W., Trowsdale, J.
Publicado 1993

BRCA1 mutations in southern England.

por Eccles, D. M., Englefield, P., Soulby, M. A., Campbell, I. G.
Publicado 1998

Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.

por Tavassoli, M., Steingrimsdottir, H., Pierce, E., Jiang, X., Alagoz, M., Farzaneh, F., Campbell, I. G.
Publicado 1996

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

por Foulkes, W. D., Stamp, G. W., Afzal, S., Lalani, N., McFarlane, C. P., Trowsdale, J., Campbell, I. G.
Publicado 1995

Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours

por Wang, Z-J, Churchman, M, Campbell, I G, Xu, W-H, Yan, Z-Y, McCluggage, W G, Foulkes, W D, Tomlinson, I P M
Publicado 1999